SPY765.31QQQ737.99+0.01%BTC/USD83,521.71−0.13%DIA513.89+0.20%GLD383.50+0.16%TLT78.56+0.42%
Benzinga

Immutep Ltd

IMMPNASDAQ
Trade with Public
Trade with Public
$4.71
-0.17-3.48%
At close: Sep 28, 5:00 PM EST
$4.61
-0.27-5.48%
Pre-Market: 4:01 AM EST
Stock Split: Immutep Ltd is expected to split Monday, September 28, 2026 with a ratio of 1:20
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentCompareOptionsStock Report

Immutep Analyst Price Targets

Wall Street analyst price targets and consensus rating for Immutep (IMMP).

Price Target Range — 3 Quarters

Analyst Consensus — 4 Analysts

2Buy
2Hold
Consensus RatingOverweight# Analysts4Avg. Consensus PT$140Upside to Avg. PT+2935.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jun 17, 2026Maxim GroupJason McCarthyUpgradeHold→Buy—
Mar 13, 2026CitizensReni BenjaminDowngradeMarket Outperform→Market Perform—
More with Benzinga EdgeGet Access

Analyst Ratings News

This Karman Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Wall Street analysts changed outlook on top names. See ratings page for upgrades, downgrades, and initiations. Analysts recommend H2O, KRMN, GNSS, WCN, and WM stocks.
Avi Kapoor

This EverCommerce Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Wall Street analysts change outlook on top companies. See analyst rating changes and their thoughts on EVCM stock before buying.
Avi Kapoor

PRO
Citizens Downgrades Immutep to Market Perform

Citizens analyst Reni Benjamin downgrades Immutep (NASDAQ:IMMP) from Market Outperform to Market Perform.
Benzinga Newsdesk

PRO
Baird Downgrades Immutep to Neutral, Lowers Price Target to $1

Baird analyst Joel Beatty downgrades Immutep (NASDAQ:IMMP) from Outperform to Neutral and lowers the price target from $7 to $1.
Benzinga Newsdesk

PRO
Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $10

Citizens analyst Reni J. Benjamin initiates coverage on Immutep (NASDAQ:IMMP) with a Market Outperform rating and announces Price Target of $10.
Benzinga Newsdesk

PRO
Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $6

Citizens analyst Reni J. Benjamin initiates coverage on Immutep (NASDAQ:IMMP) with a Market Outperform rating and announces Price Target of $6.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved